Results 161 to 170 of about 35,440 (172)

Sunitinib loaded chitosan nanoparticles formulation and its evaluation

International Journal of Biological Macromolecules, 2016
Thandapani Gomathi, D Sangeetha
exaly  

Prospective Clinical Trial of Preoperative Sunitinib in Patients With Renal Cell Carcinoma

Journal of Urology, 2010
Gregory Wilding, Bin Tean Teh, Hyung Kim   +2 more
exaly  

A phase II study of sunitinib in patients with recurrent epithelial ovarian and primary peritoneal carcinoma: an NCIC Clinical Trials Group Study

Annals of Oncology, 2011
Elizabeth Eisenhauer, J J Biagi, A M Oza   +2 more
exaly  

Heart failure associated with sunitinib malate

Cancer, 2008
, Marc Halushka
exaly  

Sunitinib-Induced Hypothyroidism Is due to Induction of Type 3 Deiodinase Activity and Thyroidal Capillary Regression

Journal of Clinical Endocrinology and Metabolism, 2011
Theo Visser, Anton H Van Den Meiracker, Mathijssen Ron H J   +2 more
exaly  

Interaction of green tea polyphenol epigallocatechin-3-gallate with sunitinib: potential risk of diminished sunitinib bioavailability

Journal of Molecular Medicine, 2011
Xingchen Peng, Qiu Meng, Liu Ji-Yan
exaly  

Phase 1 study of concurrent sunitinib and image‐guided radiotherapy followed by maintenance sunitinib for patients with oligometastases

Cancer, 2009
Jamie Cesaretti, Johnny Kao
exaly  

Mitochondrial oxidative stress plays a critical role in the cardiotoxicity of sunitinib

Toxicology, 2019
Stephan Krähenbühl, Jamal Bouitbir
exaly  

Brain accumulation of sunitinib is restricted by P‐glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and can be enhanced by oral elacridar and sunitinib coadministration

International Journal of Cancer, 2012
Alfred Schinkel
exaly  

Sunitinib rechallenge in metastatic renal cell carcinoma patients

Cancer, 2010

exaly